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Human papillomaviruses (HPVs) are epitheliotropic viruses, and their life cycle is intimately linked to the stratification and
differentiation state of the host epithelial tissues. Defining a role for the E5 gene product in the differentiation-dependent viral
life cycle has been difficult due to the lack of a suitable culture system. We used the organotypic (raft) culture system to
investigate the spatial and temporal expression pattern of the E5 protein during the differentiation-dependent life cycle of
HPV-31b. We report the generation of antisera specific to the HPV-31b E5a protein. The HPV-31b E5a protein was detected
throughout the viral life cycle in raft cultures as determined by immunostaining analyses, and the protein was localized
predominantly to the basal and granular layers. Expression of epidermal growth factor receptor or platelet-derived growth
factor receptors, two proteins with which E5 has been shown to interact in cell culture, did not specifically colocalize with
E5a expression. However, HPV-31b E5a expression did colocalize with the epithelial differentiation-specific marker filaggrin.
The kinetics of E5a protein expression during the complete viral life cycle was analyzed by immunoblotting, and the highest
level was found to be coincidental with the onset of virion morphogenesis. © 1998 Academic Press
INTRODUCTION
Human papillomaviruses (HPVs) are small DNA vi-
ruses. To date, .75 different types of HPVs have been
described (Myers et al., 1996). Papillomaviruses have
a tropism for specific epithelial tissues, and their life
cycle is intimately linked to the differentiation state of
their host tissues (Broker and Botchan, 1986; Salzman
and Howley, 1987; zur Hausen and Schneider, 1987;
Howley, 1996). Papillomavirus infection leads to local-
ized hyperproliferation of the epithelium. These le-
sions are generally benign, but in some cases they
can progress to malignancy (zur Hausen and Schnei-
der, 1987). HPV is the etiological agent for most ano-
genital cancers, with HPV-16 and HPV-18 being re-
sponsible for the largest incidence of cervical cancer
(zur Hausen and Schneider, 1987).
The life cycle of the papillomaviruses is linked to the
degree of differentiation of the tissues they infect (Broker
and Botchan, 1986; zur Hausen and Schneider, 1987;
Meyers et al., 1992; Ozbun and Meyers, 1997). Current
models predict that papillomaviruses infect basal cells
through a microtrauma of the epithelium as has been
shown with herpes simplex virus type 1 (Visalli et al.,
1997). The papillomavirus enters a basal cell, early
genes are expressed, and a maintenance copy number
of the viral genome is established. After a basal cell
mitotic event, one daughter cell remains in the basal
layer, and the other cell migrates up into the suprabasal
strata and initiates a complex program of terminal differ-
entiation. The viral genome is amplified to high copy
numbers in preparation for packaging as the host cell is
transiting the granular layer (Bedell et al., 1991; Lambert,
1991; Meyers et al., 1992, 1997b; Frattini et al., 1996).
Concomitantly, viral late genes are expressed, and virion
particles are assembled in the upper epithelial strata
(Meyers et al., 1992, 1997b; Frattini et al., 1996).
Determination of the function of some papillomavirus
gene products in the vegetative replication of the virus
has been hampered due to the lack of a suitable cell
culture system. The organotypic culture system has been
used to demonstrate the complete differentiation-depen-
dent life cycle of HPV-31b and HPV-18 in vitro (Meyers et
al., 1992, 1997b). Raft cultures of latently infected cells
were used as a model system for characterizing late
gene transcripts (Hummel et al., 1992; Ozbun and Meyers,
1997), something that was not possible to accomplish in
monolayer cultures.
We used the raft culture system to study the expres-
sion of the HPV-31b E5a gene product during the differ-
entiation-dependent life cycle of HPVs. We observed the
spatial expression of E5a to be predominantly localized
to the basal and granular layers. We assayed for colo-
calized expression of E5a, epidermal growth factor re-
ceptor (EGFR), and platelet-derived growth factor recep-
tors (PDGFRs), proteins known to associate with the E5
protein of other papillomaviruses (Goldstein and Schle-
gel, 1990; Finbow et al., 1991; Goldstein et al., 1991; Petti
and DiMaio, 1994; Hwang et al., 1995) and did not find a
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direct correlation. However, we report that HPV-31b E5a
expression did colocalize with the expression of the
epithelial-specific differentiation marker filaggrin. Finally,
as determined by immunoblot analyses, we show that
E5a protein was detected at the highest level coincident
with the onset of virion morphogenesis.
RESULTS
HPV-31b E5a protein antisera generation
HPV-31b has two open reading frames (ORFs), E5a
and E5b, in the region corresponding to the E5 ORF of
other HPVs (Fig. 1A). The HPV-31b E5a ORF shows ho-
mology with the E5 of other HPVs (Myers et al., 1996).
The early polyadenylation signal is located immediately
after the E5a ORF (Fig. 1A), making the E5a ORF present
on most early viral polycistronic transcripts. Therefore,
analysis of the expression of E5a mRNAs in raft tissue
sections could be misleading. To overcome this problem,
we investigated HPV-31b E5a protein expression.
HPV-31b E5a protein is predicted to be an 84-amino-
acid hydrophobic protein (Figs. 1B and 1C). To generate
antisera to E5a, peptides were synthesized correspond-
ing to the first 14 amino acids and the last 14 amino acids
of the E5a protein (Fig. 1B). Because the peptides were
very hydrophobic and could be solubilized only in harsh
organic solvents, linking the peptides to a carrier such as
keyhole limpet hemocyanin (KLH) was not possible. Free
insoluble peptides were injected into New Zealand White
rabbits to elicit an immune response (Hwang et al., 1995).
As determined by enzyme-linked immunosorbent assay
(ELISA), both antisera specifically recognized nickel col-
umn purified HisE5a (data not shown).
Spatial expression of E5a by immunostaining
analyses
To determine the spatial expression pattern of the E5a
protein, immunostaining analyses were performed using
the E5a N-terminal antiserum on untreated CIN-612 9E
and protein kinase C (PKC)-activated CIN-612 9E raft
tissues. Treatment with PKC activators such as the syn-
thetic diacylglycerol, 1,2-dioctanoyl-sn-glycerol (C8), has
been shown to cause a more complete differentiation of
and efficient virion morphogenesis in CIN-612 9E raft
tissues (Meyers et al., 1992; Ozbun and Meyers, 1996).
Raft epithelia were grown and harvested at 2, 4, 6, 8, 10,
12, 14, and 16 days after lifting the collagen matrices to
the air–liquid interface. Immunostaining of tissue sec-
tions with the E5a N-terminal antiserum, anti-31bE5a-N,
revealed that E5a was detected sporadically in raft tis-
sues as early as 2 days (Figs. 2A and 2F). The E5a
protein was predominantly localized to the basal and
granular layers of the epithelium (Fig. 2). PKC activation
with concomitant efficient virion morphogenesis did not
appear to have a significant effect on E5a localization in
these tissues (compare Figs. 2A–2D and 2K–2N with
Figs. 2F–2I and 2P–2S, respectively).
FIG. 1. (A) Genomic structure of HPV-31b. ORFs are indicated by the open boxes. Promoters are indicated by bent arrows, and polyadenylation sites
are indicated by downward-pointing arrows. The position of the E5a ORF is shown in the enlarged section. (B) Amino acid composition of E5a. The
amino acid sequence was aligned with the ORF. Peptide antisera were generated to the underlined regions. (C) Hydrophobic profile (Kyte and
Doolittle, 1982) for E5a. The hydrophobicity profile was aligned to the amino acid sequence to demonstrate the general hydrophobic nature of the
peptides used to generate anti-peptide immune sera.
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FIG. 2. Spatial expression of E5a in CIN-612 9E raft tissues. Tissue sections were immunostained for HPV-31b E5a using anti-31bE5a-N antiserum.
Arrowheads point to representative cells positive for E5a expression. Untreated (A–D and K–N) and PKC activation by C8 treatment (F–I and P–S)
CIN-612 9E raft cultures were grown and harvested at 2 (A and F), 4 (B and G), 6 (C and H), 8 (D and I), 10 (K and P), 12 (L and Q), 14 (M and R), and
16 (N and S) days. Negative (E and J) and positive (O and T) controls are raft culture tissues grown from primary human keratinocytes infected with
the parental retroviral vector (E and J), LXSN, or the recombinant HPV-31b E5a retroviral rector (O and T), 31bE5aKLX, respectively.
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To determine the specificity of the N-terminal anti-
serum, immunostaining analyses was further tested by
immunostaining primary foreskin raft epithelium trans-
duced with a recombinant retrovirus that expressed HPV-
31b E5a (Figs. 2O and 2T), the parental retrovirus (Figs.
2E and 2J), and uninfected primary foreskin raft epithe-
lium (data not shown). E5a-specific staining was readily
detectable in the tissues transduced with a recombinant
retrovirus encoding E5a, but it was not detectable in the
tissues transduced with a parental retrovirus or the pri-
mary foreskin raft epithelium.
Colocalization of E5a protein with cellular proteins
E5 from other papillomaviruses has been shown to
associate with the PDGFRs and the EGFR (Goldstein and
FIG. 3. PDGFR and EGFR expression in CIN-612 9E raft tissues. C8-treated CIN-612 9E raft culture tissues harvested at 8 days and immunostained
for PDGFR (A) and EGFR (B).
FIG. 4. HPV-31b E5a and filaggrin colocalization in CIN-612 9E raft tissues. Adjacent sections of C8-treated CIN-612 9E raft tissues harvested at
6 (A, B, D, and E), 10 (C, F, and G), and 12 (H, I, K, and L) days immunostained with anti-31bE5a-N antiserum for the HPV-31b E5a protein (A–C and
G–I) or with a filaggrin-specific monoclonal antibody (D–F and J–L). The arrowheads point to representative cells in adjacent tissue sections (A/D, B/E,
C/F, G/I, H/K, and I/L) that were positive for both expression of E5a and filaggrin.
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Schlegel, 1990; Finbow et al., 1991; Goldstein et al., 1991;
Petti and DiMaio, 1994; Hwang et al., 1995). To determine
whether these growth factor receptors colocalized with
the expression of E5a, adjacent tissue sections of un-
treated 9E and PKC-activated 9E raft tissues were immu-
nostained (Fig. 3). Because both PDGFR (Fig. 3A) and
EGFR (Fig. 3B) were expressed throughout the tissues, it
was unclear as to the precise nature of any potential
receptor colocalization with E5a expression in raft epi-
thelia.
Involucrin and filaggrin are markers of epithelial differ-
entiation. Involucrin is expressed throughout the supra-
basal layers, whereas filaggrin is typically expressed
only in the granular and cornified layers (Ball et al., 1978;
Dale et al., 1985, 1987). To test whether E5a expression
colocalized with the expression of these epithelial differ-
entiation markers, adjacent sections of untreated 9E and
PKC-activated 9E raft epithelium were immunostained.
Involucrin expression showed no specific colocalization
with E5a expression at any of the time points (data not
shown). However, E5a expression did colocalize with
filaggrin expression (Fig. 4). Contrary to what is observed
in normal tissues, filaggrin expression was observed in
the basal layer.
Temporal expression of the E5a protein
To characterize the specificity of the C-terminal E5a
antiserum, immunoblot analyses were performed on re-
combinant proteins generated by infecting insect cells
with recombinant baculoviruses. The C-terminal anti-
serum anti-31bE5a-C was specific for the HisE5a and the
wild-type E5a proteins (Fig. 5, lanes 1 and 2, respective-
ly). The antiserum did not recognize proteins from unin-
fected Sf9 cells (Fig. 5, lane 3) or irrelevant papillomavi-
rus proteins generated from recombinant baculovirus
infections (Fig. 5, lanes 4 and 5). The bands that migrated
at ;30 kDa are suggestive of a dimeric form of E5a (Fig.
5, lane 2). This is based on size, specificity, and results
with other papillomavirus E5 proteins (Burkhardt et al.,
1987; Horwitz et al., 1988; Goldstein and Schlegel, 1990;
Kell et al., 1994; Sparkowski et al., 1994). The HisE5a
protein also showed a slowly migrating band suggestive
of dimerization but not to the extent of the wild-type E5a
protein. The latter was observed by probing blots with
the His-tag-specific antiserum, revealing HisE5a mono-
mer and HisE5a dimer (data not shown).
To determine the kinetics of E5a expression during the
differentiation-dependent virus life cycle, immunoblot
analyses were performed on whole raft lysates (Fig. 6).
Both a monomeric form and a dimeric form of E5a were
detected in raft epithelium (Fig. 6). In both untreated and
PKC-activated 9E raft tissue lysates, E5a monomer was
detected at day 8 (Fig. 6, lanes 4 and 11, respectively).
FIG. 5. Western blot of recombinant baculovirus generated E5a
proteins. Insect cells were infected with recombinant baculovirus,
and whole cell lysates were immunoblotted for HPV-31b E5a using
the anti-31bE5a-C antiserum. Note: Monomeric and dimeric forms of
E5a are present in E5a lanes. Molecular mass markers are indicated
in kDa.
FIG. 6. Temporal expression of HPV-31b E5a protein during the differentiation-dependent viral life cycle. Untreated CIN-612 9E (lanes 3–7) and
PKC-activated (C8-treated) CIN-612 9E (lanes 10–14) were harvested at 4, 8, 10, 12, and 16 days. Primary raft tissue (lane 8) was used as a negative
control to demonstrate antiserum specificity. Equal amounts of raft extract were immunoblotted for HPV-31b E5a protein using the affinity purified
anti-31bE5a-C antiserum. CIN-612 9E monolayer extracts are shown in lane 2. Baculovirus-generated E5a protein (lanes 1 and 9) were loaded to serve
as an internal marker for the location of E5a in the gels. Arrows indicate the position of E5a monomer and dimer.
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However, the monomeric form of the E5a protein dimin-
ishes as the life cycle of the virus progresses. The
potential dimeric form was also first detected at day 8,
but it increased to a maximal level at 10–12 days in both
the untreated and PKC-activated CIN-612 9E raft tissue
lysates (Fig. 6, lanes 4–7 and 11–14, respectively). Inter-
estingly, day 10 is the time point at which the beginning
of virion morphogenesis has been observed in the raft
culture system (Ozbun and Meyers, 1997). Therefore, E5a
was expressed at the highest level coincidental with the
onset of virion morphogenesis. The specificity of the
affinity purified anti-31bE5a-C antiserum was demon-
strated by immunoblotting primary keratinocyte raft tis-
sue lysate (Fig. 6, lane 8).
DISCUSSION
The E5 proteins from HPVs are small hydrophobic
proteins with an unknown function or functions in the
differentiation-dependent life cycle of the virus. To date,
all work on defining a function or functions for these
proteins have been done in monolayer cultures. Specif-
ically, the HPV-16 E5 protein has been shown to stimu-
late the transforming activity of EGFR in the presence of
EGF (Leptak et al., 1991; Leechanachai et al., 1992; Pim
et al., 1992), to affect the down-regulation of EGFR by
inhibiting endosomal acidification (Straight et al., 1993,
1995), and to affect cell–cell communication in keratino-
cytes (Oelze et al., 1995). HPV-16 E5 has been shown to
bind to several cellular proteins, including EGFR, PDGFR,
CSF-1R, p185neu (Hwang et al., 1995), and the 16-kDa
subunit of a vacuolar H1-ATPase (Conrad et al., 1993;
Chen et al., 1996). Furthermore, HPV-16 E5 has been
shown to increase mitogen-activated protein kinase ac-
tivity (Gu and Matlashewski, 1995), to increase c-fos
expression in response to serum and growth factor re-
ceptor ligands EGF and PDGF (Leechanachai et al.,
1992), and to cause repression of p21 expression at the
transcriptional level (Tsao et al., 1996). The E5a protein of
HPV-6 has been shown to accelerate the generation time
of mouse fibroblasts, cause anchorage-independent
growth, and cause overgrowth in confluent monolayer
cultures (Chen and Mounts, 1990; Leechanachai et al.,
1992). As a first step to understanding the role of E5 in
the vegetative replication of HPV, we used organotypic
cultures to investigate the spatial and temporal expres-
sion pattern of the HPV-31b E5a protein during the life
cycle of the virus.
To study E5a expression in organotypic cultures of
CIN-612 9E raft tissues, it was first necessary to generate
antisera to the HPV-31b E5a protein. HPV-31b E5a, like all
papillomavirus E5 proteins, is extremely hydrophobic,
and thus it is difficult to generate an immunogenic re-
sponse to this protein. The peptides generated were not
soluble in aqueous solutions, so conventional carrier
coupling methods could not be used. Therefore, free
self-aggregated peptides were injected into rabbits to
evoke an immune response. We report the generation of
two antisera specific for the E5a protein from HPV-31b
that were used to study E5a protein expression in raft
tissues during the differentiation-dependent life cycle of
the HPV.
The current model for the function of E5 in the differ-
entiation-dependent life cycle of the papillomavirus pre-
dicts E5 to interact with cellular growth factor receptors,
resulting in the transduction of proliferation signals to the
nucleus (DiMaio et al., 1994). BPV-1 E5 may do this by
binding to the mature and immature PDGFR and causing
activation of this receptor family in the absence of ligand
(Petti et al., 1991; Goldstein et al., 1994; Petti and DiMaio,
1994; Drummond-Barbosa et al., 1995; Nilson et al., 1995;
Sparkowski et al., 1995). BPV-1 E5 has also been pro-
posed to affect signaling through the EGFR. The 16-kDa
subunit of a vacuolar H1-ATPase has also been shown to
interact with E5, and this interaction has been predicted
to associate with the EGFR (Goldstein and Schlegel,
1990; Finbow et al., 1991; Goldstein et al., 1991). In the
case of HPV-16 E5, the EGFR is recycled to the cell
surface (Straight et al., 1993, 1995). E5 does not directly
activate the EGFR, but rather E5 functions to increase the
half-life of the receptor on the cell surface. We wanted to
determine whether there was a correlation in the expres-
sion for these growth factor receptors and the E5a pro-
tein from HPV-31b during the viral life cycle in raft tis-
sues. Because E5a was detected sporadically through-
out these tissues, it is unknown whether the E5a protein
was affecting the level of expression and the tissue
localization of PDGFR and EGFR expression in these
tissues.
We found colocalized expression of HPV-31b E5a and
filaggrin in raft epithelium. The cells expressing filaggrin
are terminally differentiated cells, and virion morphogen-
esis has been observed in such cells (Meyers et al.,
1992). As discussed below, E5 may have a role in sig-
naling virion morphogenesis and thus is coexpressed
with filaggrin. Filaggrin was also expressed in the lower
epithelial cell layers in this study. Work with allergic
contact dermatitis agents, such as nickel sulfate, has
revealed that in irritated tissues, filaggrin is expressed in
the lower epithelial layers (Meyers and Huber, 1997a).
These data suggest HPV E5 proteins may imitate the
actions of an irritant in the epithelium.
We found the E5a protein to be localized predomi-
nantly to the basal and granular layers during the differ-
entiation-dependent life cycle of HPV in rat cultures.
Previous studies using in situ hybridization revealed E5
ORF-containing transcripts at high levels throughout the
epithelial tissues (Stoler et al., 1989, 1990; Beyer-Finkler
et al., 1990). In the xenograft system, the E5 transcript
was shown to be expressed very early in the HPV-11 life
cycle, and levels increased as virion morphogenesis
ensued (Stoler et al., 1990). E5 protein was not investi-
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gated in these studies and in light of our results demon-
strates a caveat in the use of transcript analyses for
determining E5 protein localization. The E5 ORF is
present on most early viral polycistronic transcripts, but
the E5 protein does not necessarily have to be present.
Therefore, detecting E5-containing transcripts may be
misleading as to the location of E5 protein in the infected
tissues.
When the tissue location of BPV-1 E5 protein was
examined in the naturally occurring bovine fibropapil-
loma, Burnett et al. (1992) found E5 to be localized to the
basal and granular layers. We found HPV-31b E5a protein
to be localized in the basal and granular layers of raft
epithelia. Papillomavirus genome amplification and
virion assembly occur in the granular layer of infected
epithelium. It is possible that there is a requirement for
E5 interaction with growth factor receptors to facilitate
the completion of the virus life cycle. Burnett et al. (1992)
also suggested a role for E5 in differentiation-dependent
virion morphogenesis.
The E5 protein of BPV-1 dimerizes via two disulfide
bridges located in the carboxyl third of the protein
(Burkhardt et al., 1987; Horwitz et al., 1988; Goldstein and
Schlegel, 1990; Sparkowski et al., 1994). Mutation of
either one of these cysteine residues abrogates the
dimerization and transforming function of the E5 protein
in transformation assays in mouse fibroblasts (Settleman
et al., 1989). We detected an aberrantly migrating species
of the HPV-31b E5a protein. Possible explanations as to
the nature of this slower migrating species are (1) a
dimerized species of E5a, (2) stable complex of E5a with
another viral or cellular protein, or (3) post-translational
modification of the E5a protein. The dimeric species was
also detected after expression of E5a from a baculovirus
recombinant vector. No other HPV gene product was
present, arguing against a complex forming between E5a
and another HPV protein. In addition, because the slower
migrating species was seen in Sf9 insect cells and in
human raft culture tissue, we believe that this strongly
suggests that the slower migration is not due to a com-
plex formation with a cellular or a post-translational mod-
ification. We also believe that this is a dimeric species,
based on studies from other laboratories demonstrating
the dimerization of E5 proteins for other papillomaviruses
(Settleman et al., 1989; Kell et al., 1994). Our samples
were boiled in the presence of reducing agents, so any
dimeric species may be forming in the absence of disul-
fide bridges. Alternatively, the disulfide bridges could be
buried in the hydrophobic core of the protein and thus
are resistant to reduction. Hydrophobic interactions be-
tween two E5a proteins could strengthen the dimeriza-
tion. Kell et al. (1994) reported detection of a dimeric
species of HPV-16 E5 from the cervical biopsy material of
patients. The samples in the report by Kell et al. (1994)
also were boiled in the presence of reducing agents, and
they still detected dimers of HPV-16 E5.
The pattern of E5 expression during the complete viral
replication cycle as determined by immunoblotting ap-
peared to be concomitant with viral DNA amplification
(Ozbun and Meyers, 1998) and virion morphogenesis
(Ozbun and Meyers, 1997). Day 10 is the point at which
efficient virion morphogenesis has been first observed in
PKC-activated 9E raft tissues (Ozbun and Meyers, 1997).
Therefore, E5a was detected at the highest levels coin-
cidental with virion morphogenesis. E5a presence does
not appear to be sufficient for efficient virion morphogen-
esis because E5a was present in untreated CIN-612 9E
raft tissues and untreated tissues do not efficiently pro-
duce HPV-31b virus (Meyers et al., 1992; Ozbun and
Meyers, 1997). We cannot, however, rule out the possi-
bility that E5a presence is necessary for virion morpho-
genesis. To address these issues, it will be necessary to
perform a mutational analysis of E5a.
We investigated the spatial and temporal expression
of HPV-31b E5a protein during the differentiation-depen-
dent viral life cycle in organotypic cultures. This is the
first report of the generation of antisera specific for the
HPV-31b E5a protein. These antisera were useful for
studying E5a expression in situ and by immunoblotting
analyses. We found the E5a protein was expressed spo-
radically in raft epithelium as early as 2 days and colo-
calized with filaggrin expression. We report the detection
of monomer and dimer E5a forms in raft epithelium and
that E5a presence coincides with virion morphogenesis.
MATERIALS AND METHODS
Cell lines
The CIN-612 9E cell line was derived from a biopsy of
a low grade cervical intraepithelial neoplasia type 1
(CIN-1) cervical lesion and contains HPV-31b DNA main-
tained in an episomal state (Hummel et al., 1992). Epi-
thelial cell lines were maintained in monolayer culture
using E medium containing 5% fetal bovine serum (Sum-
mit Biotechnology, Fort Collins, Colorado) in the pres-
ence of mitomycin C-treated J2 3T3 feeder cells (Mc-
Cance et al., 1988; Meyers et al., 1994; Meyers, 1996).
Primary foreskin keratinocytes were pooled cultures of
foreskin explants (Clonetics, Walkersville, Maryland) and
were maintained in KGM medium (Clonetics, San Diego,
California).
Organotypic (raft) cultures were grown as previously
reported (Meyers et al., 1994; Meyers, 1996). Raft epithe-
lial tissues were grown at the air–liquid interface for 2–16
days. Treatment of rafts with 10 mM 1,2-dioctanoyl-sn-
glycerol (C8) (Sigma Chemical, St. Louis, Missouri) was
performed every other day. Media were changed every
other day on all raft cultures.
The 293 cells were cultured in Dulbecco’s modified
Eagle’s medium (Irvine Sciences, Irvine, California) sup-
plemented with 10% fetal bovine serum (Summit Biotech-
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nology). The insect cell line Sf9 was maintained in
Grace’s medium (GIBCO BRL, Gaithersburg, Maryland).
The cells were cultured at 27°C in 100-mm petri dishes
sealed in plastic bags to control humidity.
Antisera generation
Antisera to the HPV-31b E5a protein was generated by
peptide immunization of New Zealand White rabbits (Co-
vance, Denver, Pennsylvania). Peptides corresponding to
the amino-terminal 14 amino acids (anti-31bE5a-N) and
the carboxyl-terminal 14 amino acids (anti-31bE5a-C)
were synthesized (Fig. 1) (Macromolecular Core Facility,
Pennsylvania State University College of Medicine, Her-
shey, PA). Then, 1 mg of each peptide was resuspended
in 500 ml of phosphate-buffered saline (PBS). The rabbits
were immunized four times each with 1 mg of peptide
per injection. The initial immunizations were done in
complete Freund’s adjuvant. The remaining three boost-
ers were done in incomplete Freund’s adjuvant. Injec-
tions were spaced 30 days apart.
Affinity column purification of the anti-31bE5a-C anti-
serum was performed with ImmunoPure affinity column
chromatography (Pierce, Rockford, IL) as follows. Insect
cells were infected with a recombinant baculovirus that
encodes for HPV-31b E5a (discussed below). The cells
were harvested at 72 h postinfection. After a PBS wash,
the cells were lysed by freezing and thawing one time.
The proteins were extracted in radioimmunoprecipitation
assay (RIPA)–PBS buffer (PBS plus 150 mM NaCl, 5 mM
Na2EDTA, 5 mM EGTA, 1 mM NaVO4, 100 mM NaF, 1%
Triton X-100, 0.1% SDS, 1% deoxycholate, 1 mM dithio-
threitol, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml
leupeptin, 1 g/ml aprotinin). The cell lysate was boiled for
10 min. After a 1-h incubation on ice, insoluble material
was removed by centrifugation. The soluble extract was
linked to the ImmunoPure (Pierce) column as recom-
mended by the manufacturer. Anti-31bE5a-C antiserum
was affinity purified for 16 h at 4°C. The column was
washed extensively with PBS to remove all unbound
antibodies. Bound antibodies were removed with 10 ml
of 100 mM glycine (pH 2.5).
Antisera to the type B PDGFR were generated by
immunization of New Zealand White rabbits (Covance)
with a synthetic peptide (Macromolecular Core Facility)
that maps to the carboxyl-terminal 13 amino acids of the
human type B PDGFR. The peptide was conjugated to
KLH (CalBiochem, La Jolla, CA) using M-maleimidoben-
zoyl N-hydroxysuccinimide ester (Pierce) according to
the recommendations of the manufacturer. Rabbits were
immunized four times as stated above. Affinity purifica-
tion was performed with ImmunoPure (Pierce) affinity
column chromatography as recommended by the manu-
facturer.
Generation of recombinant baculoviruses
The E5a ORF was amplified using polymerase chain
reaction (PCR). Primers were generated to amplify nu-
cleotides (nt) 3811–4094 within the HPV-31b genome
(Myers et al., 1996). All primers were synthesized at
Operon Technologies (San Diego, CA). The 59 primer had
a Kozak consensus sequence engineered around the
start site of E5a (Kozak, 1986). The 39 primer had a BamHI
site engineered after the E5a stop codon. The 59 and 39
primer sequences were as follows: 59-GCC ACC ATG
ATT GAA C-39 and 59-CAG GAT CCT TCA ACA GTA TAC
ACA AG-39, respectively. PCR conditions were as follows:
1 cycle of 94°C for 4 min, 30 cycles of 94°C for 30 s, 60°C
for 1 min, and 72°C for 1 min. This was followed by one
cycle of 72°C for 10 min. The PCR product was cloned
into the TA Cloning Vector (InVitrogen, San Diego, CA) to
generate pCR31bE5aK. Dideoxy sequencing was per-
formed using Sequenase Version 2.0 (United States Bio-
chemical, Cleveland, OH) to ensure that there were no
mutations in the E5a ORF and that the Kozak consensus
sequence was properly inserted. The sequence, desig-
nated E5aK, was removed from pCR31bE5aK by diges-
tion with EcoRI and BamHI and was cloned into pVL1392
(InVitrogen). This vector was transfected into the insect
cell line Sf9 with linearized wild-type baculovirus using
Bac-N-Blue (InVitrogen) as recommended by the manu-
facturer. Recombinant plaques were picked and assayed
for production of the E5a protein.
To generate the 63 histidine-tagged E5a protein, prim-
ers were generated to amplify nt 3811–4094 of the HPV-
31b genome. BamHI restriction sites were engineered
into both primers. The 59 and 39 primer sequences are as
follows: 59-CTG GAT CCT GGC CTA ATG ATT GAA C-39
and 59-CAG GAT CCT TCA ACA GTA TAC ACA AG-39,
respectively. PCR conditions were as stated above. The
PCR product was digested with BamHI and cloned into
pGEM3Zf(2) (Promega, Madison, Wisconsin) to generate
pTM31bE5a. Clones were sequenced to ensure no mu-
tations were present. The E5a gene was removed from
pTM31bE5a using BamHI digestion and cloned into
pBlueBacHisB (InVitrogen) so an intact reading frame
was generated encoding a 34-amino-acid His-tag fused
to the amino terminus of the E5a protein. This vector was
transfected into the insect cell line Sf9 with linearized
wild-type baculovirus DNA as stated above, and recom-
binant plaques were picked and assayed for production
of the HisE5a protein.
Recombinant baculovirus stocks HPV-6 L1 and cotton-
tail rabbit papillomavirus (CRPV) E2 and the anti-His-tag
antiserum were kind gifts from Dr. Neil Christensen.
Recombinant HPV-31b E5a retroviruses
Recombinant retroviruses were generated using the
pCL vector system (Naviaux et al., 1996). The E5aK se-
quence was cloned into pCLXSN (a kind gift from Dr.
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Inder Verma) at the EcoRI and BamHI sites. Recombinant
retroviral stocks were generated in 293 cells as de-
scribed (Naviaux et al., 1996). Primary foreskin keratino-
cytes were infected with 1 ml of viral stock plus 100
mg/ml Polybrene (Aldrich Chemical Company, Milwau-
kee, WI) for 2 h. At 24 h later, the infection was repeated.
The cells were cultured to confluence and passaged to
collagen matrices for growth in raft cultures.
Histochemical analyses
After growth at the air–liquid interface, raft tissues
were harvested, fixed in 10% neutral buffered Formalin,
and embedded in paraffin. Four m thin sections were cut
for analyses. Immunohistochemical analyses were per-
formed with the Vectastain Elite Kit (Vector Laboratories,
Burlingame, CA) as recommended by the manufacturer.
The primary antibodies used included EGFR polyclonal
antiserum (1:1500; Santa Cruz Biotechnology, Santa Cruz,
CA), affinity purified PDGFR polyclonal antiserum (1:150),
E5a N-terminal polyclonal antiserum (1:750), involucrin
polyclonal antiserum (1:5; Biogenesis, Sandown, NH),
and filaggrin monoclonal antibody (1:50; BT-576, Biomed-
ical Technologies Inc., Stoughton, MA).
Immunoblot analyses
Recombinant baculovirus stocks were used to infect
the insect cell line Sf9. At 72 h postinfection, the cells
were harvested and washed once in PBS. Cells were
lysed by freezing and thawing once. Proteins were
extracted from Sf9 cells with RIPA buffer. Protein sam-
ples were boiled in 23 sample buffer (0.125 M Tris–
HCl, pH 6.8, 4% SDS, 10% glycerol, and 10% 2-b-
mercaptoethanol) for 5 min, and proteins were sepa-
rated by 15% SDS–PAGE.
Proteins were extracted from raft tissues in ice-cold
RIPA buffer. Tissues were disrupted by sonication
once on ice for 30 s followed by a 1-h incubation on
ice. Insoluble materials was pelleted. Sample buffer
(63) was added to one tenth of each of the whole raft
lysates (;100–300 mg of total protein), and the sam-
ples were boiled for 5 min. Proteins were separated by
15% SDS–PAGE.
Proteins were transferred to a PVDF membrane (Mil-
lipore Corporation, Bedford, MA). The membrane was
blocked with 5% milk protein in PBS for 1 h at room
temperature. The blots were probed with the affinity
purified anti-31bE5a-C (in blocking buffer) at 4°C for 16 h.
Immunodetection was performed with anti-rabbit horse-
radish peroxidase (1:15,000; Amersham) in blocking
buffer. Enhanced chemiluminescence (Amersham) was
used to visualize the proteins as recommended by the
manufacturer. The blots were expressed to Reflection
NEF film (DuPont NEN, Boston, MA).
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